Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17beta-estradiol | multiple interactions | ISO | Plcb2 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLCB2 mRNA | CTD | PMID:32741896 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of PLCB2 mRNA | CTD | PMID:31614463 | 17beta-estradiol 3-benzoate | multiple interactions | ISO | Plcb2 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLCB2 mRNA | CTD | PMID:32741896 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Plcb2 (Mus musculus) | 6480464 | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of PLCB2 mRNA] | CTD | PMID:16891777 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Plcb2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PLCB2 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Plcb2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PLCB2 mRNA | CTD | PMID:16891777 | 6-propyl-2-thiouracil | increases expression | ISO | Plcb2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of PLCB2 mRNA | CTD | PMID:24780913 and PMID:25825206 | acetamide | increases expression | ISO | Plcb2 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of PLCB2 mRNA | CTD | PMID:31881176 | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of PLCB2 exon | CTD | PMID:30157460 | aldehydo-D-glucose | multiple interactions | ISO | Plcb2 (Rattus norvegicus) | 6480464 | acetovanillone inhibits the reaction [Glucose results in increased expression of PLCB2 protein] and CAT protein inhibits the reaction [Glucose results in increased expression of PLCB2 protein] | CTD | PMID:20691780 | aldehydo-D-glucose | increases expression | ISO | Plcb2 (Rattus norvegicus) | 6480464 | Glucose results in increased expression of PLCB2 protein | CTD | PMID:20691780 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of PLCB2 mRNA | CTD | PMID:33167477 | all-trans-retinoic acid | multiple interactions | ISO | Plcb2 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PLCB2 mRNA | CTD | PMID:36189433 | allethrin | multiple interactions | ISO | Plcb2 (Rattus norvegicus) | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PLCB2 protein | CTD | PMID:34896426 | ammonium chloride | affects expression | ISO | Plcb2 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of PLCB2 mRNA | CTD | PMID:16483693 | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of PLCB2 mRNA | CTD | PMID:24449571 | apocynin | multiple interactions | ISO | Plcb2 (Rattus norvegicus) | 6480464 | acetovanillone inhibits the reaction [Glucose results in increased expression of PLCB2 protein] and acetovanillone inhibits the reaction [Streptozocin results in increased expression of PLCB2 protein] | CTD | PMID:20691780 | arsane | multiple interactions | ISO | Plcb2 (Mus musculus) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PLCB2 mRNA | CTD | PMID:32045263 | arsenic atom | multiple interactions | ISO | Plcb2 (Mus musculus) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PLCB2 mRNA | CTD | PMID:32045263 | atrazine | increases expression | ISO | Plcb2 (Rattus norvegicus) | 6480464 | Atrazine results in increased expression of PLCB2 mRNA | CTD | PMID:36841081 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of PLCB2 promoter | CTD | PMID:27901495 | bisphenol A | increases expression | ISO | Plcb2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of PLCB2 mRNA | CTD | PMID:26141625 | bisphenol A | increases methylation | ISO | Plcb2 (Mus musculus) | 6480464 | bisphenol A results in increased methylation of PLCB2 promoter | CTD | PMID:27312807 | bisphenol A | decreases expression | ISO | Plcb2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of PLCB2 mRNA | CTD | PMID:25181051 more ... | bisphenol F | decreases expression | ISO | Plcb2 (Rattus norvegicus) | 6480464 | 4 and 4'-bisphenol F results in decreased expression of PLCB2 mRNA | CTD | PMID:26186136 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of PLCB2 gene | CTD | PMID:31601247 | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to PLCB2 gene] | CTD | PMID:28238834 | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of PLCB2 mRNA | CTD | PMID:27594783 | Cuprizon | increases expression | ISO | Plcb2 (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of PLCB2 mRNA | CTD | PMID:27523638 | cyhalothrin | multiple interactions | ISO | Plcb2 (Rattus norvegicus) | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PLCB2 protein | CTD | PMID:34896426 | cypermethrin | multiple interactions | ISO | Plcb2 (Rattus norvegicus) | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PLCB2 protein | CTD | PMID:34896426 | cytarabine | affects localization | EXP | | 6480464 | Cytarabine affects the localization of PLCB2 protein | CTD | PMID:9295281 | cytarabine | multiple interactions | EXP | | 6480464 | edelfosine inhibits the reaction [Cytarabine affects the localization of PLCB2 protein] | CTD | PMID:9295281 | D-glucose | multiple interactions | ISO | Plcb2 (Rattus norvegicus) | 6480464 | acetovanillone inhibits the reaction [Glucose results in increased expression of PLCB2 protein] and CAT protein inhibits the reaction [Glucose results in increased expression of PLCB2 protein] | CTD | PMID:20691780 | D-glucose | increases expression | ISO | Plcb2 (Rattus norvegicus) | 6480464 | Glucose results in increased expression of PLCB2 protein | CTD | PMID:20691780 | daidzein | multiple interactions | ISO | Plcb2 (Rattus norvegicus) | 6480464 | daidzein promotes the reaction [GNB1 protein results in increased activity of PLCB2 protein results in increased activity of MAPK1 protein] more ... | CTD | PMID:16972265 | dapsone | multiple interactions | EXP | | 6480464 | Dapsone inhibits the reaction [Paraquat results in increased phosphorylation of PLCB2 protein] | CTD | PMID:20164675 | dextran sulfate | multiple interactions | ISO | Plcb2 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLCB2 mRNA | CTD | PMID:29950665 | diquat | decreases expression | ISO | Plcb2 (Mus musculus) | 6480464 | Diquat results in decreased expression of PLCB2 mRNA | CTD | PMID:36851058 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of PLCB2 mRNA | CTD | PMID:29803840 | edelfosine | multiple interactions | EXP | | 6480464 | edelfosine inhibits the reaction [Cytarabine affects the localization of PLCB2 protein] and edelfosine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PLCB2 protein] | CTD | PMID:9295281 | ethanol | increases expression | ISO | Plcb2 (Mus musculus) | 6480464 | Ethanol results in increased expression of PLCB2 mRNA | CTD | PMID:30319688 | fenvalerate | multiple interactions | ISO | Plcb2 (Rattus norvegicus) | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PLCB2 protein | CTD | PMID:34896426 | fonofos | decreases methylation | EXP | | 6480464 | Fonofos results in decreased methylation of PLCB2 promoter | CTD | PMID:22847954 | FR900359 | decreases phosphorylation | EXP | | 6480464 | FR900359 results in decreased phosphorylation of PLCB2 protein | CTD | PMID:37730182 | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of PLCB2 gene | CTD | PMID:31601247 | furan | decreases expression | ISO | Plcb2 (Rattus norvegicus) | 6480464 | furan results in decreased expression of PLCB2 mRNA | CTD | PMID:25539665 | glucose | multiple interactions | ISO | Plcb2 (Rattus norvegicus) | 6480464 | acetovanillone inhibits the reaction [Glucose results in increased expression of PLCB2 protein] and CAT protein inhibits the reaction [Glucose results in increased expression of PLCB2 protein] | CTD | PMID:20691780 | glucose | increases expression | ISO | Plcb2 (Rattus norvegicus) | 6480464 | Glucose results in increased expression of PLCB2 protein | CTD | PMID:20691780 | lidocaine | increases expression | ISO | Plcb2 (Rattus norvegicus) | 6480464 | Lidocaine results in increased expression of PLCB2 mRNA | CTD | PMID:35283115 | mono(2-ethylhexyl) phthalate | decreases expression | ISO | Plcb2 (Mus musculus) | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of PLCB2 mRNA | CTD | PMID:22401849 | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Plcb2 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PLCB2 mRNA | CTD | PMID:36189433 | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of PLCB2 mRNA | CTD | PMID:24810058 | nitrates | decreases expression | ISO | Plcb2 (Rattus norvegicus) | 6480464 | Nitrates results in decreased expression of PLCB2 mRNA | CTD | PMID:30022042 | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of PLCB2 mRNA | CTD | PMID:35430440 | paraquat | increases phosphorylation | EXP | | 6480464 | Paraquat results in increased phosphorylation of PLCB2 protein | CTD | PMID:20164675 | paraquat | multiple interactions | EXP | | 6480464 | Dapsone inhibits the reaction [Paraquat results in increased phosphorylation of PLCB2 protein] | CTD | PMID:20164675 | parathion | decreases methylation | EXP | | 6480464 | Parathion results in decreased methylation of PLCB2 promoter | CTD | PMID:22847954 | phorbol 13-acetate 12-myristate | affects localization | EXP | | 6480464 | Tetradecanoylphorbol Acetate affects the localization of PLCB2 protein | CTD | PMID:9295281 | phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | edelfosine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PLCB2 protein] | CTD | PMID:9295281 | pyrethrins | decreases expression | ISO | Plcb2 (Rattus norvegicus) | 6480464 | Pyrethrins results in decreased expression of PLCB2 protein | CTD | PMID:34896426 | quercitrin | affects expression | EXP | | 6480464 | quercitrin affects the expression of PLCB2 mRNA | CTD | PMID:25193878 | serpentine asbestos | increases expression | EXP | | 6480464 | Asbestos and Serpentine results in increased expression of PLCB2 mRNA | CTD | PMID:21148743 | silicon dioxide | increases expression | ISO | Plcb2 (Rattus norvegicus) | 6480464 | Silicon Dioxide results in increased expression of PLCB2 mRNA | CTD | PMID:32721576 | sodium arsenite | affects expression | EXP | | 6480464 | sodium arsenite affects the expression of PLCB2 mRNA | CTD | PMID:34032870 | sodium arsenite | multiple interactions | ISO | Plcb2 (Mus musculus) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PLCB2 mRNA | CTD | PMID:32045263 | streptozocin | multiple interactions | ISO | Plcb2 (Rattus norvegicus) | 6480464 | acetovanillone inhibits the reaction [Streptozocin results in increased expression of PLCB2 protein] and CAT protein inhibits the reaction [Streptozocin results in increased expression of PLCB2 protein] | CTD | PMID:20691780 | streptozocin | increases expression | ISO | Plcb2 (Rattus norvegicus) | 6480464 | Streptozocin results in increased expression of PLCB2 protein | CTD | PMID:20691780 | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of PLCB2 mRNA | CTD | PMID:31533062 | terbufos | decreases methylation | EXP | | 6480464 | terbufos results in decreased methylation of PLCB2 promoter | CTD | PMID:22847954 | testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of PLCB2 mRNA | CTD | PMID:33359661 | testosterone | multiple interactions | ISO | Plcb2 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLCB2 mRNA | CTD | PMID:32741896 | titanium dioxide | multiple interactions | ISO | Plcb2 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLCB2 mRNA | CTD | PMID:29950665 | triptonide | increases expression | ISO | Plcb2 (Mus musculus) | 6480464 | triptonide results in increased expression of PLCB2 mRNA | CTD | PMID:33045310 | tungsten | decreases expression | ISO | Plcb2 (Mus musculus) | 6480464 | Tungsten results in decreased expression of PLCB2 mRNA | CTD | PMID:30912803 | |